Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
The prospects of minocycline in multiple sclerosis.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Tumor-like multiple sclerosis.
Recommendations for the management of multiple sclerosis relapses.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
MAIT cells in autoimmunity.
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Neuromuscular taping in multiple sclerosis. A pilot study.
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Multiple sclerosis: summary of NICE guidance.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.

Pages